SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19Lars F. Westblade, Michael J. Satlin, Dakai Liu et al.|Cancer Cell|2020Cited by 232
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103Chaitra S. Ujjani, Bruce D. Cheson, Sin‐Ho Jung et al.|Blood|2016Cited by 59
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemiaCristina Rueda, Rafael Zaragoza, Mireia Puig‐Asensio et al.|Clinical Microbiology and Infection|2016Cited by 57
The Bruton's Tyrosine Kinase Inhibitor PCI-32765 Is Highly Active As Single-Agent Therapy in Previously-Treated Mantle Cell Lymphoma (MCL): Preliminary Results of a Phase II TrialLühua Wang, André Goy, Peter Martin et al.|Blood|2011Cited by 41
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohortLuis Eduardo López-Cortés, David Navarro, Benito Almirante et al.|Clinical Microbiology and Infection|2016Cited by 39